Vicore Pharma AB SEC Filings
NASDAQ: VCREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
9.00+0.18 (+2.04%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Vicore Pharma AB filing overview
This page lists 3 recent SEC filings by Vicore Pharma AB (VCRE), including 3 6-K. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
VCRE SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Sep 30, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Aug 21, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jul 6, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |